NCT03506568View on ClinicalTrials.gov

A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

June 4, 2021

Study Completion Date

June 4, 2021

Conditions
Medication AdherenceGlaucoma
Interventions
DEVICE

Devers Drop Device (D3) app

A universal eye drop cap monitor that accurately measures and improves eye drop-taking behavior.

Trial Locations (1)

97210

Robert Kinast, Portland

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Oregon State University

OTHER

collaborator

National Eye Institute (NEI)

NIH

lead

Universal Adherence LLC

INDUSTRY

NCT03506568 - A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications | Biotech Hunter | Biotech Hunter